SCHEMBL14375905

SCHEMBL14375905

Cc1ccc(NC(=O)Nc2ccc(CN3C(C)(C)C(=O)NS3(=O)=O)cc2)cc1Nc1ncccn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 18/20 0.41
▸ BCR P11274 15/20 0.41
▸ PDGFRA P16234 4/20 0.41
▸ KIT P10721 8/20 0.40
▸ ABL2 P42684 2/20 0.40
▸ BRAF P15056 2/20 0.40
▸ MAPK14 Q16539 2/20 0.40
▸ PLK4 O00444 1/20 0.40
▸ DDX3X O00571 1/20 0.40
▸ GAK O14976 1/20 0.40
▸ SLC22A2 O15244 1/20 0.40
▸ MAPK13 O15264 1/20 0.40
▸ CA12 O43570 1/20 0.40
▸ SLC22A3 O75751 1/20 0.40
▸ ABCB11 O95342 1/20 0.40
▸ EGFR P00533 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ ALB P02768 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14375882 0.91 PDGFRA (0.51) ABL1BCRPDGFRAKITABL2
SCHEMBL14375873 0.85 MAPK14 (0.44) ABL1BCRPDGFRAKITABL2
SCHEMBL14375868 0.80 PDGFRA (0.59) ABL1BCRPDGFRAKITABL2
SCHEMBL14375853 0.80 PDGFRA (0.71) ABL1BCRPDGFRAKITABL2
SCHEMBL14375827 0.78 MAPK14 (0.49) ABL1BCRPDGFRAKITABL2
SCHEMBL14375933 0.77 ALDH1A1 (0.56) ABL1BCRPDGFRAKITABL2
SCHEMBL14375894 0.76 ABL1 (0.44) ABL1BCRPDGFRAKITABL2
SCHEMBL14375903 0.76 PDGFRA (0.44) ABL1BCRPDGFRAKITABL2
SCHEMBL14375923 0.75 ABL1 (0.43) ABL1BCRPDGFRAKITKDR
SCHEMBL14375920 0.71 HPGD (0.41) CA12LMNACYP3A4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7279576-B2 Anti-cancer medicaments DECIPHERA PHARMACEUTICALS, LLC (US) 2007-10-09 — — US disclosed
Send feedback